- InnoSer expands its preclinical neuroscience expertise with the acquisition of Sylics
- InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model
- InnoSer expands preclinical cancer readout capabilities through acquisition of new imagers.
- Discussing innovation and the PDX/O platform at SINERGIA Summer School
- Facility management and preclinical services discussed at the FELASA Congress